A low 1,25-dihydroxy vitamin D result means the active hormone form of vitamin D, also called calcitriol, is below the lab’s reference range. This result is most often interpreted in the context of kidney function, parathyroid hormone, calcium, phosphorus, and 25-hydroxy vitamin D. It does not usually mean the same thing as a standard “low vitamin D” result, because the usual test for vitamin D stores is 25-hydroxy vitamin D. The kidneys normally convert 25-hydroxy vitamin D into 1,25-dihydroxy vitamin D when the body needs more calcium absorption and mineral balance. When kidney function falls, or when parathyroid hormone is too low, this conversion can drop. A low result may be part of chronic kidney disease, hypoparathyroidism, severe vitamin D deficiency, inherited vitamin D activation disorders, or complex calcium-phosphorus problems that need follow-up.
- Low 1,25-dihydroxy vitamin D usually means reduced calcitriol production, most often from kidney disease or low parathyroid hormone.
- This is not the preferred first test for vitamin D stores; 25-hydroxy vitamin D is usually used for that purpose.
- Adult reference ranges often run around 18–64 pg/mL in males and 18–78 pg/mL in females, but ranges vary by lab.
- Calcium, phosphorus, PTH, creatinine, eGFR, and 25-hydroxy vitamin D give the result its meaning.
- Low calcitriol can contribute to low calcium, high PTH, bone mineral problems, and CKD-mineral and bone disorder.
- Urgent care is important for severe low-calcium symptoms such as spasms, seizures, fainting, confusion, or heart rhythm symptoms.
Table of Contents
- What a Low 1,25-Dihydroxy Vitamin D Result Means
- Why Kidney Function Affects Calcitriol
- Common Causes of Low 1,25-Dihydroxy Vitamin D
- How to Interpret Calcium, Phosphorus, and PTH
- Symptoms and When Low Results Matter
- Follow-Up Tests to Consider
- Treatment and Next Steps
What a Low 1,25-Dihydroxy Vitamin D Result Means
A low 1,25-dihydroxy vitamin D test means the active vitamin D hormone in the blood is lower than expected for the lab method being used. This active form is also called calcitriol or 1,25(OH)2D. Its main job is to help regulate calcium and phosphorus balance, especially by increasing calcium absorption from the intestine.
This test is different from the more common 25-hydroxy vitamin D test. The 25-hydroxy form reflects the body’s vitamin D supply from sun exposure, food, and supplements. The 1,25-dihydroxy form reflects how the body is activating vitamin D in response to kidney function, parathyroid hormone, calcium, phosphorus, and other signals. For a deeper comparison, see 25-hydroxy vitamin D versus 1,25-dihydroxy vitamin D.
A low calcitriol result can be meaningful, but it is rarely interpreted alone. For example, someone can have low 25-hydroxy vitamin D but normal or high 1,25-dihydroxy vitamin D because parathyroid hormone is pushing the kidneys to activate more vitamin D. Another person can have normal 25-hydroxy vitamin D but low 1,25-dihydroxy vitamin D because the kidneys cannot activate it well.
Many laboratories report 1,25-dihydroxy vitamin D in picograms per milliliter (pg/mL). One commonly used adult reference range is about 18–64 pg/mL for males and 18–78 pg/mL for females, with a pediatric range around 24–86 pg/mL for people younger than 16. These numbers are not universal. Different labs, instruments, and reporting systems can use different cutoffs, so the best first step is to compare your result with the reference interval printed on your own report.
The test is usually most helpful when the clinician is looking beyond ordinary vitamin D stores. It may be ordered in chronic kidney disease, unexplained calcium or phosphorus abnormalities, suspected hypoparathyroidism, rare inherited vitamin D metabolism disorders, or some cases of hypercalcemia. The related 1,25-dihydroxy vitamin D normal range can help explain why a “normal” result may still need context.
Why Kidney Function Affects Calcitriol
The kidneys are central to calcitriol production. Vitamin D from the skin, food, or supplements is first converted in the liver into 25-hydroxy vitamin D. Then the kidneys use an enzyme called 1-alpha-hydroxylase to convert 25-hydroxy vitamin D into 1,25-dihydroxy vitamin D. This second step is tightly controlled.
Parathyroid hormone, often shortened to PTH, usually increases calcitriol production when blood calcium is low. Low calcium tells the parathyroid glands to release more PTH. PTH then signals the kidneys to activate more vitamin D, which helps the intestines absorb more calcium. This feedback system helps keep calcium in a narrow range.
Chronic kidney disease can weaken this system. As functioning kidney tissue declines, the kidneys may lose some ability to activate vitamin D. At the same time, phosphorus may build up, fibroblast growth factor 23 (FGF23) may rise, and PTH may increase. These changes can reduce calcitriol and contribute to the pattern known as CKD-mineral and bone disorder.
This is why a low 1,25-dihydroxy vitamin D result often leads to a closer look at vitamin D and kidney function blood tests. Creatinine and eGFR show how well the kidneys are filtering. Calcium and phosphorus show the mineral side of the problem. PTH shows how hard the parathyroid glands are trying to correct the imbalance.
A common pattern in moderate to advanced CKD is low or falling calcitriol, normal or low-normal calcium, high or rising phosphorus, and high PTH. This pattern does not mean the body simply needs high-dose over-the-counter vitamin D. It may require careful management of phosphorus intake, vitamin D stores, PTH, calcium exposure, medications, and kidney disease stage.
Common Causes of Low 1,25-Dihydroxy Vitamin D
Low 1,25-dihydroxy vitamin D has several possible causes. The most likely cause depends on the rest of the lab pattern and the clinical setting.
| Cause | Why calcitriol may be low | Labs that often help clarify it |
|---|---|---|
| Chronic kidney disease | The kidneys activate less 25-hydroxy vitamin D into calcitriol | Creatinine, eGFR, phosphorus, calcium, PTH, urine albumin |
| Hypoparathyroidism | Low PTH gives the kidneys too little activation signal | Low or inappropriately normal PTH, low calcium, high phosphorus |
| Severe vitamin D deficiency | There may be too little 25-hydroxy vitamin D substrate to activate | 25-hydroxy vitamin D, calcium, PTH, alkaline phosphatase |
| High FGF23 states | FGF23 suppresses calcitriol production and increases phosphate wasting | Phosphorus, urinary phosphate, FGF23 in selected cases |
| Rare inherited activation disorders | Genetic changes can impair vitamin D activation or response | Calcium, phosphorus, PTH, alkaline phosphatase, genetic testing |
| Medication or illness effects | Some drugs and serious illnesses can alter vitamin D metabolism | Medication review, liver/kidney tests, mineral panel |
Chronic kidney disease is one of the most important causes because calcitriol production depends heavily on healthy kidney tissue. A low result may appear before calcium becomes clearly low, especially when PTH is still compensating. Trends in creatinine and eGFR help show whether reduced kidney function is part of the explanation.
Hypoparathyroidism is another classic cause. In this condition, PTH is too low or not strong enough for the body’s needs. Without enough PTH signal, the kidneys may not activate enough vitamin D. The typical pattern is low calcium, high phosphorus, and low or inappropriately normal PTH.
Severe vitamin D deficiency can sometimes lower calcitriol, but early or moderate deficiency may not. In many people with low 25-hydroxy vitamin D, PTH rises and stimulates calcitriol production, so 1,25-dihydroxy vitamin D may look normal or high. This is one reason the active form should not be used as the routine screening test for nutritional vitamin D status. The standard nutrient-storage test is covered in 25-hydroxy vitamin D testing.
Rare causes include vitamin D-dependent rickets type 1, in which the body cannot activate vitamin D properly, and vitamin D receptor resistance, in which the body cannot respond to calcitriol normally. These are usually considered in children or young adults with bone disease, low calcium, abnormal phosphorus, high alkaline phosphatase, and a pattern that does not fit common deficiency.
How to Interpret Calcium, Phosphorus, and PTH
The meaning of low 1,25-dihydroxy vitamin D becomes much clearer when calcium, phosphorus, and PTH are reviewed together. Calcitriol helps raise calcium and phosphorus absorption from the gut. PTH helps raise calcium, lower phosphorus through kidney excretion, and stimulate calcitriol production. The kidneys help coordinate all of these signals.
A low calcitriol result with low calcium and high phosphorus points toward reduced PTH effect, hypoparathyroidism, or kidney-related mineral imbalance. A low calcitriol result with high PTH often suggests the parathyroid glands are trying to compensate for low calcium absorption, low vitamin D stores, high phosphorus, or reduced kidney activation capacity. A low calcitriol result with normal calcium can still matter if phosphorus, PTH, or kidney markers are abnormal.
The pattern is often more useful than any single value:
| Lab pattern | Possible meaning | Why follow-up matters |
|---|---|---|
| Low calcitriol, high PTH, high phosphorus | Common CKD-mineral balance pattern | May affect bone strength and vascular calcification risk |
| Low calcitriol, low calcium, low or normal PTH | Possible hypoparathyroidism | May need calcium and active vitamin D management |
| Low calcitriol, low 25-hydroxy vitamin D, high PTH | Severe vitamin D deficiency or mixed deficiency pattern | Requires correction without overcorrecting calcium or phosphorus |
| Low calcitriol, low eGFR, rising phosphorus | Reduced kidney activation of vitamin D | May need CKD-focused mineral management |
| Low calcitriol, normal calcium, normal PTH | Mild, early, transient, or lab-context finding | Repeat testing or broader review may be enough in some cases |
Calcium deserves special attention because symptoms often come from low ionized calcium rather than calcitriol itself. Total calcium can be misleading when albumin is abnormal, so clinicians may correct calcium for albumin or order ionized calcium. If calcium is low, the related low calcium blood test pattern can help explain symptoms and urgency.
Phosphorus is also important, especially in CKD. High phosphorus can stimulate PTH and FGF23 and can worsen mineral-bone imbalance. In kidney disease, phosphorus may rise because the kidneys cannot excrete it well. The combination of high phosphorus, abnormal PTH, and low calcitriol can place stress on bones and blood vessels.
PTH ties the pattern together. A high PTH level may be an appropriate response to low calcium, low vitamin D stores, or kidney disease. A low PTH level can be inappropriate when calcium is low. A normal PTH level can still be “inappropriately normal” if the body should be making much more. Reviewing the PTH blood test normal range is helpful, but the calcium and phosphorus context matters just as much.
Symptoms and When Low Results Matter
Low 1,25-dihydroxy vitamin D itself may not cause obvious symptoms at first. Many people only learn about it because testing was done for kidney disease, abnormal calcium, bone problems, or unexplained PTH changes. Symptoms are more likely when the low calcitriol is causing or contributing to low calcium, high PTH, bone mineral problems, or advanced CKD-mineral and bone disorder.
Possible symptoms linked to low calcium or mineral imbalance include muscle cramps, tingling around the mouth, numbness in the hands or feet, muscle spasms, fatigue, bone pain, joint pain, and increased fracture risk over time. In children, long-term mineral imbalance can affect bone growth and shape. In adults, the effects may be quieter and appear slowly as bone weakness, fractures, or CKD-related bone disease.
Medical attention is urgent when symptoms suggest severe hypocalcemia or heart rhythm problems. These include painful muscle spasms, hand or facial twitching, seizures, fainting, confusion, severe weakness, chest pain, or a racing or irregular heartbeat. A low calcitriol lab result alone is not usually an emergency, but low calcium symptoms can be.
The result matters more when it appears with any of these findings:
- Low calcium, especially low ionized calcium
- High phosphorus
- High or unexpectedly low PTH
- Low eGFR or known chronic kidney disease
- Bone pain, fractures, or low bone density
- History of parathyroid surgery, thyroid surgery, or autoimmune parathyroid disease
- Childhood rickets, poor growth, or bone deformity
- Malabsorption, bariatric surgery, inflammatory bowel disease, or very low vitamin D stores
It is also important not to treat the number in isolation. Raising calcitriol pharmacologically can raise calcium and phosphorus absorption. In the wrong setting, this may increase the risk of high calcium, high phosphorus, kidney stones, or soft-tissue calcification. This is especially important in people with CKD, where mineral levels may change slowly and require close monitoring.
Follow-Up Tests to Consider
Follow-up testing usually focuses on why calcitriol is low and whether calcium-phosphorus balance is affected. The exact panel depends on symptoms, kidney function, age, medications, and prior results.
Common follow-up tests include:
- 25-hydroxy vitamin D to assess vitamin D stores
- Total calcium and albumin, or ionized calcium when accuracy is important
- Phosphorus
- Intact PTH
- Creatinine and eGFR
- Magnesium, because low magnesium can impair PTH release and action
- Alkaline phosphatase, including bone-specific alkaline phosphatase in selected cases
- Urine calcium in people with kidney stones, hypoparathyroidism, or calcium treatment
- Urine albumin-to-creatinine ratio when CKD is suspected or monitored
- Bone density testing when fracture risk or CKD-bone disease is a concern
A clinician may also review medications and supplements. Calcium supplements, vitamin D, calcitriol, phosphate binders, diuretics, anticonvulsants, glucocorticoids, magnesium-containing products, and some osteoporosis medicines can all affect interpretation. The dose and form matter. Plain vitamin D3 or D2 raises 25-hydroxy vitamin D stores, while prescription calcitriol is already active and can raise calcium more directly.
Timing can matter too. Fasting is sometimes preferred for this test but is not always required. Because 1,25-dihydroxy vitamin D is tightly regulated and can shift with illness or mineral changes, a single mildly low value may need repeat testing if the rest of the panel does not fit.
In CKD, one isolated result is less useful than a trend. Clinicians often follow calcium, phosphorus, PTH, alkaline phosphatase, 25-hydroxy vitamin D, and kidney function over time. A related calcium, phosphorus, and PTH pattern can show whether the body is compensating, underproducing PTH, retaining phosphorus, or developing secondary hyperparathyroidism.
Bone symptoms, fractures, or very abnormal PTH may lead to additional evaluation. Bone density testing can help in some CKD patients, although it does not show all forms of renal osteodystrophy. Bone biopsy is rarely used, but it may be considered in complex CKD-related bone disease when the diagnosis is unclear and treatment decisions are difficult.
Treatment and Next Steps
Treatment depends on the cause. A low 1,25-dihydroxy vitamin D result is not automatically treated with over-the-counter vitamin D or prescription calcitriol. The safest plan depends on kidney function, calcium, phosphorus, PTH, and 25-hydroxy vitamin D.
If 25-hydroxy vitamin D is low and kidney function is normal, clinicians often treat vitamin D deficiency with vitamin D3 or D2 and then recheck levels. In this setting, the goal is usually to rebuild vitamin D stores, not to force calcitriol higher directly. Calcium intake, diet quality, sun exposure, malabsorption risk, body weight, and medication use may all affect the plan.
If chronic kidney disease is the main issue, treatment is usually broader. It may include correcting vitamin D stores, managing dietary phosphorus, using phosphate binders when needed, adjusting calcium exposure, treating secondary hyperparathyroidism, and using active vitamin D medicines only when appropriate. In CKD, too much active vitamin D can raise calcium and phosphorus, so monitoring is essential.
If hypoparathyroidism is the cause, treatment may involve calcium, active vitamin D such as calcitriol, magnesium correction, and careful urine calcium monitoring. The goal is not simply to normalize every blood value, but to reduce symptoms while avoiding high urine calcium, kidney stones, or kidney damage.
If the result is part of a rare inherited disorder, treatment is more specialized. Children or adults with rickets, repeated low calcium, high alkaline phosphatase, unusual phosphorus levels, or family history may need evaluation by endocrinology, nephrology, or genetics.
Practical next steps after a low result are:
- Compare the result with the lab’s own reference range and units.
- Check whether 25-hydroxy vitamin D was measured separately.
- Review calcium, phosphorus, PTH, creatinine, eGFR, magnesium, and alkaline phosphatase.
- Ask whether the pattern fits kidney disease, hypoparathyroidism, severe deficiency, medication effects, or a rarer disorder.
- Avoid starting high-dose vitamin D, calcium, or calcitriol without a clinician’s plan if calcium, phosphorus, PTH, or kidney function is abnormal.
- Seek urgent care for severe low-calcium symptoms, seizures, fainting, confusion, chest pain, or irregular heartbeat.
Diet and supplements should be individualized. Someone with ordinary vitamin D deficiency may need more vitamin D-rich foods or supplements. Someone with CKD and high phosphorus may need to limit phosphorus additives and follow a kidney-specific nutrition plan. Someone with low calcium from hypoparathyroidism may need active vitamin D and calcium under monitoring. The same low calcitriol number can lead to very different next steps.
A helpful way to think about the result is this: 25-hydroxy vitamin D shows supply, while 1,25-dihydroxy vitamin D shows activation and hormone regulation. Low activation can be a clue to kidney, parathyroid, or mineral-balance problems. The safest interpretation comes from the full pattern, not from the calcitriol result alone.
References
- DHVD – Overview: 1,25-Dihydroxyvitamin D, Serum 2026 (Official Laboratory Test Page)
- Vitamin D – Health Professional Fact Sheet 2025 (Official Fact Sheet)
- Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline 2024 (Guideline)
- Mineral & Bone Disorder in Chronic Kidney Disease 2021 (Official Patient and Professional Education Page)
- KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) 2017 (Guideline)
Disclaimer
A low 1,25-dihydroxy vitamin D result should be interpreted with your medical history, kidney function, calcium, phosphorus, PTH, and 25-hydroxy vitamin D. Do not start calcitriol, high-dose vitamin D, or high-dose calcium without medical guidance, especially if you have kidney disease, abnormal phosphorus, kidney stones, or heart rhythm symptoms. Seek urgent care for severe spasms, seizures, fainting, confusion, chest pain, or an irregular heartbeat.
